Intrahepatic cholangiocarcinoma. Results of aggressive surgical management

Arch Surg. 1995 Oct;130(10):1073-8. doi: 10.1001/archsurg.1995.01430100051011.

Abstract

Objective: To report the results of a deliberately aggressive surgical management in patients with intrahepatic cholangiocarcinoma.

Design: A case series of patients with intrahepatic cholangiocarcinoma.

Setting: A tertiary care university hospital in a metropolitan area.

Patients: From 1989 to 1993, 19 patients with intrahepatic cholangiocarcinoma underwent laparotomy, with a 74% resectability rate (14 liver resections). In addition, two selected patients with a slow-growing tumor underwent orthotopic liver transplantation after limited recurrence following resection in one case and after exploratory laparotomy in the other.

Interventions: The 14 liver resections included six right or left hepatectomies and eight extended right or left hepatectomies. Total vascular exclusion of the liver was used in nine cases (64%) and resection of the biliary confluence with reconstruction was used in six cases (43%).

Results: There was one postoperative death (7%). There were four postoperative biliary fistulas (28%). Overall actuarial 1- and 2-year survival rates were 58% and 32%, respectively. The 1- and 2-year survival rates were 100% after curative resection (no lymph node invasion, clearance margin of < or = 1 cm, and solitary tumor [five cases]) and 48% and 10% after palliative resection. Median survival was 14 months for the whole series and 27 and 9 months following curative and palliative resections, respectively. The two liver transplant recipients are alive and free of disease at 25 and 31 months.

Conclusion: These results support aggressive surgical management in patients with intrahepatic cholangiocarcinoma, including complex liver resection procedures and selective use of orthotopic liver transplantation.

MeSH terms

  • Actuarial Analysis
  • Adult
  • Aged
  • Anastomosis, Roux-en-Y
  • Carcinoma, Hepatocellular / diagnosis
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / surgery
  • Chemotherapy, Adjuvant
  • Cholangiocarcinoma / diagnosis
  • Cholangiocarcinoma / mortality
  • Cholangiocarcinoma / surgery*
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Hepatectomy
  • Humans
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / mortality
  • Liver Neoplasms / surgery*
  • Liver Transplantation
  • Lymph Node Excision
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / surgery
  • Radiotherapy, Adjuvant
  • Survival Rate